LL Capital Corp.
TSX VENTURE : LLA.P

June 25, 2015 19:26 ET

LL Capital Corp. Announces TSXV Conditional Approval, SEDAR Filing of Filing Statement and Further Details on the Proposed Acquisition of Syncordia Technologies and Healthcare Solutions, Inc.

TORONTO, ONTARIO--(Marketwired - June 25, 2015) - LL Capital Corp. (the "Corporation") (TSX VENTURE:LLA.P) is pleased to announce that it has received conditional approval from the TSX Venture Exchange (the "TSXV") relating to its previously announced proposed qualifying transaction (the "Proposed Transaction") with Syncordia Technologies and Healthcare Solutions, Inc. ("Syncordia"). The Proposed Transaction is currently scheduled to close on or about June 29, 2015. A filing statement prepared in accordance with the requirements of the TSXV in connection with the Proposed Transaction has been filed with the TSXV and the applicable Canadian securities regulators on SEDAR and is available at www.sedar.com.

For additional information about the Proposed Transaction, please see the Corporation's press releases dated April 13, 2015 and June 12, 2015, respectively, which are available at www.sedar.com.

ABOUT SYNCORDIA

Syncordia has operations in North America and Europe, and is focused on investing in, partnering with and growing revenue cycle management ("RCM") companies where proprietary technology can be used as an accelerator. Syncordia addresses a great void in niche healthcare sectors, such as EMS and behavioral health, where the necessary workflow/production/analytic components are largely absent or inadequate for a RCM company to maintain quality with scale. Syncordia is actively acquiring medical billing companies and is building a proprietary suite of RCM software solutions called the Syncordia Cloud, which includes patient scheduling, electronic health records, claims management, analytics and more. Syncordia's ability to not only offer but control the entire product offering of both software and solutions uniquely positions the company to be able to deliver a refreshingly simple and powerful product offering that's largely absent in healthcare today. Led by a team of executives with extensive experience in RCM and technology, acquisition opportunities are carefully selected to become part of the Syncordia family and enable Syncordia's vision of becoming a world class technology enhanced RCM Company with best in class solutions.

ABOUT LL CAPITAL

The Corporation is a capital pool company formed under the TSXV capital pool company program.

Completion of the Proposed Transaction is subject to a number of conditions, including but not limited to, negotiation and execution of definitive transaction documentation, obtaining any necessary governmental and third party approvals and final TSXV acceptance. There can be no assurance that the transaction will be completed as proposed or at all.

Investors are cautioned that, except as disclosed in the filing statement prepared in connection with the Proposed Transaction, any information released or received with respect to the transaction may not be accurate or complete and should not be relied upon. Trading in the securities of a capital pool company should be considered highly speculative.

The TSX Venture Exchange Inc. has in no way passed upon the merits of the Proposed Transaction and has neither approved nor disapproved the contents of this press release.

Certain information in this press release may contain forward-looking statements. This information is based on current expectations that are subject to significant risks and uncertainties that are difficult to predict. Actual results might differ materially from results suggested in any forward-looking statements. The Corporation assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward looking-statements unless and until required by securities laws applicable to the Corporation. Additional information identifying risks and uncertainties is contained in filings by the Corporation with the Canadian securities regulators, which filings are available at www.sedar.com.

The Corporation's common shares will remain halted until such time as permission to resume trading has been obtained from the TSXV. The Corporation is a reporting issuer in Alberta, British Columbia and Ontario.

NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Contact Information